ECOG-ACRIN Staff

April 15, 2020
Dr. O'Dwyer and Dr. Schnall
April 15, 2020
Categories

From the Co-Chairs, March/April 2020

Seamless patient mangement during the pandemic; COVID-19 Virtual Town Hall for Community Physicians and Research Staff; remembering Dr. Uma Rao; recognizing the John H. Stroger, Jr. Hospital of Cook County Minority Underserved NCORP; spotlight on the EROS trial, which is evaluating a program to help women with cancer and their physicians plan for reproductive health and preservation of sexuality during and after cancer treatment
Do you like it?
0 Read more
April 15, 2020
Patient in office
April 15, 2020
Categories

Now Enrolling: EA1181 Decreasing Chemotherapy in HER2 Positive Breast Cancer

For patients who have a pathologic complete response (pCR) after 12 weeks of pre-operative THP (single agent taxane plus trastuzumab and pertuzumab), is it safe to omit additional therapy after surgery?
Do you like it?
0 Read more
February 28, 2020
Dr. O'Dwyer and Dr. Schnall
February 28, 2020
Categories

From the Co-Chairs, February 2020

January meeting with NCI leaders and the Cooperative Group Chairs; Congress increases NCI and overall NIH budget for FY 2020; EA opens two new trials, one for pancreatic cyst monitoring (EA2185) and the other to evaluate nivolumab in head and neck cancer (EA3161); plans are underway for the next Comis Symposium
Do you like it?
0 Read more
January 14, 2020
Dr. O'Dwyer and Dr. Schnall
January 14, 2020
Categories

From the Co-Chairs, December 2019/January 2020

Reflecting on key milestones in 2019: TMIST breast cancer screening trial continues to ramp up; NCORP grant renewal emphasizes screening, symptom control, and cancer care delivery research; new role for Dr. Al Benson; E1912's practice-changing trial results; update on Dr. Otis Brawley's efforts to form the Social Determinants of Health Working Group; EA launches the Comis Symposium
Do you like it?
0 Read more
123456789101112